Nihon Kohden (OTCMKTS:NHNKY) Sees Unusually-High Trading Volume - Should You Buy?

Key Points

• Shares saw an unusually-high trading volume of about 63,235 shares (up ~120% from 28,792) and last traded at $9.45, modestly above the prior close of $9.29.
• UBS upgraded Nihon Kohden from "hold" to a "strong-buy", and MarketBeat shows the company's average analyst rating as "Strong Buy."
• The stock is trading below both its 50‑day ($10.61) and 200‑day ($11.05) moving averages; fundamentals include a $1.62B market cap, P/E ~18.6, quarterly EPS $0.16 on $362.86M revenue, and a low beta of 0.39.

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report) saw unusually-strong trading volume on Wednesday . Approximately 63,235 shares were traded during mid-day trading, an increase of 120% from the previous session's volume of 28,792 shares.The stock last traded at $9.45 and had previously closed at $9.29.

Analyst Upgrades and Downgrades

Separately, UBS Group raised Nihon Kohden from a "hold" rating to a "strong-buy" rating in a research report on Monday, January 19th. One investment analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the company has an average rating of "Strong Buy".

Nihon Kohden Price Performance

The stock's fifty day simple moving average is $10.61 and its 200-day simple moving average is $11.05. The stock has a market cap of $1.62 billion, a P/E ratio of 18.61 and a beta of 0.39.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last announced its quarterly earnings results on Thursday, February 5th. The company reported $0.16 earnings per share for the quarter. The business had revenue of $362.86 million for the quarter. Nihon Kohden had a return on equity of 7.25% and a net margin of 5.32%.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan's earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company's core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.